Focus

Teva

LATEST

Courts
Courts

Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute

Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute
|
US News
US News

Drug Maker Teva Reaches Proposed $4.25 Billion Settlement Over Alleged Role in Opioid Crisis

Drug Maker Teva Reaches Proposed $4.25 Billion Settlement Over Alleged Role in Opioid Crisis
|
Companies
Companies

San Francisco Reaches $58 Million Opioid Settlement With Teva, Allergan

San Francisco Reaches $58 Million Opioid Settlement With Teva, Allergan
|
US News
US News

Teva, Allergan Reach $161.5 Million Opioid Settlement With West Virginia

Teva, Allergan Reach $161.5 Million Opioid Settlement With West Virginia
|
Companies
Companies

Walgreens, Teva Accused of Fueling Opioid Addiction in Quest for New Markets

Walgreens, Teva Accused of Fueling Opioid Addiction in Quest for New Markets
|
Companies
Companies

Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds

Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
|
Companies
Companies

Teva Settles Shareholder Lawsuit Over Generic Drug Pricing for $420 Million

Teva Settles Shareholder Lawsuit Over Generic Drug Pricing for $420 Million
|
Companies
Companies

Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York

Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
|
Companies
Companies

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

Teva Pharm to pay Oklahoma $85 million to settle opioid claims
|
US News
US News

FDA: Two More Blood Pressure Drugs Recalled Over Possible Cancer Risk

FDA: Two More Blood Pressure Drugs Recalled Over Possible Cancer Risk
|
Courts
Courts

Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute

Supreme Court Rejects Teva Challenge to $235 Million GSK Award in Patent Dispute
|
US News
US News

Drug Maker Teva Reaches Proposed $4.25 Billion Settlement Over Alleged Role in Opioid Crisis

Drug Maker Teva Reaches Proposed $4.25 Billion Settlement Over Alleged Role in Opioid Crisis
|
Companies
Companies

San Francisco Reaches $58 Million Opioid Settlement With Teva, Allergan

San Francisco Reaches $58 Million Opioid Settlement With Teva, Allergan
|
US News
US News

Teva, Allergan Reach $161.5 Million Opioid Settlement With West Virginia

Teva, Allergan Reach $161.5 Million Opioid Settlement With West Virginia
|
Companies
Companies

Walgreens, Teva Accused of Fueling Opioid Addiction in Quest for New Markets

Walgreens, Teva Accused of Fueling Opioid Addiction in Quest for New Markets
|
Companies
Companies

Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds

Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
|
Companies
Companies

Teva Settles Shareholder Lawsuit Over Generic Drug Pricing for $420 Million

Teva Settles Shareholder Lawsuit Over Generic Drug Pricing for $420 Million
|
Companies
Companies

Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York

Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
|
Companies
Companies

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

Teva Pharm to pay Oklahoma $85 million to settle opioid claims
|
US News
US News

FDA: Two More Blood Pressure Drugs Recalled Over Possible Cancer Risk

FDA: Two More Blood Pressure Drugs Recalled Over Possible Cancer Risk
|